We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIVO
1801
DELISTED
Tivo Inc
TIVO
$816K ﹤0.01%
51,133
+7,900
+18% +$139K
RYL
1802
DELISTED
RYLAND GROUP INC
RYL
$814K ﹤0.01%
17,546
+2,100
+14% +$93.3K
OWW
1803
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$814K ﹤0.01%
71,300
+30,700
+76% +$355K
BEL
1804
DELISTED
Belmond Ltd.
BEL
$813K ﹤0.01%
65,100
-1,069,870
-94% -$13.5M
BLKB icon
1805
Blackbaud
BLKB
$2B
$809K ﹤0.01%
14,200
HEI icon
1806
HEICO Corp
HEI
$51.3B
$805K ﹤0.01%
33,691
MGEE icon
1807
MGE Energy Inc
MGEE
$3.07B
$804K ﹤0.01%
20,750
MLKN icon
1808
MillerKnoll
MLKN
$1.63B
$803K ﹤0.01%
27,750
TEF
1809
DELISTED
Telefonica
TEF
$796K ﹤0.01%
74,253
+6,095
+9% +$67.2K
CNSL
1810
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$796K ﹤0.01%
37,892
+15,100
+66% +$314K
HRC
1811
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$796K ﹤0.01%
14,650
+1,500
+11% +$77.9K
CACI icon
1812
CACI
CACI
$14.9B
$793K ﹤0.01%
9,800
+2,300
+31% +$200K
WSO icon
1813
Watsco Inc
WSO
$12.9B
$792K ﹤0.01%
6,400
PPO
1814
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$790K ﹤0.01%
13,200
VSTO
1815
DELISTED
Vista Outdoor Inc.
VSTO
$784K ﹤0.01%
17,450
CSG
1816
DELISTED
CHAMBERS STR PPTYS COM
CSG
$780K ﹤0.01%
98,100
AMN icon
1817
AMN Healthcare
AMN
$1.31B
$779K ﹤0.01%
24,657
+7,700
+45% +$201K
UNT
1818
DELISTED
UNIT Corporation
UNT
$776K ﹤0.01%
28,600
-35,400
-55% -$1.12M
FWRD icon
1819
Forward Air
FWRD
$681M
$775K ﹤0.01%
14,835
ITGR icon
1820
Integer Holdings
ITGR
$4.26B
$774K ﹤0.01%
15,742
KLXI
1821
DELISTED
KLX Inc.
KLXI
$774K ﹤0.01%
20,789
+4,291
+26% +$155K
BRX icon
1822
Brixmor Property Group
BRX
$9.17B
$770K ﹤0.01%
33,300
+9,200
+38% +$224K
TKR icon
1823
Timken Company
TKR
$9.09B
$768K ﹤0.01%
21,000
SJI
1824
DELISTED
South Jersey Industries, Inc.
SJI
$768K ﹤0.01%
31,040
RPAI
1825
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
$763K ﹤0.01%
54,800

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.